Cite
Minigene Splicing Assays Identify 20 Spliceogenic Variants of the Breast/Ovarian Cancer Susceptibility Gene RAD51C.
MLA
Sanoguera-Miralles, Lara, et al. “Minigene Splicing Assays Identify 20 Spliceogenic Variants of the Breast/Ovarian Cancer Susceptibility Gene RAD51C.” Cancers, vol. 14, no. 12, June 2022, p. 2960–N.PAG. EBSCOhost, https://doi.org/10.3390/cancers14122960.
APA
Sanoguera-Miralles, L., Bueno-Martínez, E., Valenzuela-Palomo, A., Esteban-Sánchez, A., Llinares-Burguet, I., Pérez-Segura, P., García-Álvarez, A., de la Hoya, M., & Velasco-Sampedro, E. A. (2022). Minigene Splicing Assays Identify 20 Spliceogenic Variants of the Breast/Ovarian Cancer Susceptibility Gene RAD51C. Cancers, 14(12), 2960–N.PAG. https://doi.org/10.3390/cancers14122960
Chicago
Sanoguera-Miralles, Lara, Elena Bueno-Martínez, Alberto Valenzuela-Palomo, Ada Esteban-Sánchez, Inés Llinares-Burguet, Pedro Pérez-Segura, Alicia García-Álvarez, Miguel de la Hoya, and Eladio A. Velasco-Sampedro. 2022. “Minigene Splicing Assays Identify 20 Spliceogenic Variants of the Breast/Ovarian Cancer Susceptibility Gene RAD51C.” Cancers 14 (12): 2960–N.PAG. doi:10.3390/cancers14122960.